Exploiting data for drug reprofiling
Lead Participant:
CRESSET BIOMOLECULAR DISCOVERY LIMITED
Abstract
The project aims to create a platform through which the partners are able to offer products and services to customers in the area of drug re-profiling or re-purposing. Re-profiling generally consists of looking for a new therapeutic application for an existing drug molecule, or stated another way, searching databases of known drug molecules to find compounds which have high similarity to a query structure of interest. Cresset and Biolauncher bring together skills in computational chemistry, large-scale textual informatics and semantic data integration to create a system which enables the provision of applications and services in such re-profiling exercises to life sciences customers.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
CRESSET BIOMOLECULAR DISCOVERY LIMITED | £458,210 | £ 208,850 |
  | ||
Participant |
||
BIOLAUNCHER LIMITED | £202,553 | £ 121,532 |
OZONE PURIFICATION LIMITED | ||
THOMSON REUTERS (SCIENTIFIC) LIMITED |
People |
ORCID iD |
Steve Gardner (Project Manager) |